Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG. (Q53227029)
Jump to navigation
Jump to search
scientific article published on 11 September 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG. |
scientific article published on 11 September 2006 |
Statements
Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG. (English)
1 reference
Ignace Vergote
1 reference
Jacobus Pfisterer
1 reference
Marie Plante
1 reference
Andreas du Bois
1 reference
Hal Hirte
1 reference
Angel J Lacave
1 reference
Uwe Wagner
1 reference
Anne Stähle
1 reference
Gavin Stuart
1 reference
Rainer Kimmig
1 reference
Sigrid Olbricht
1 reference
Tien Le
1 reference
Janusz Emerich
1 reference
Walther Kuhn
1 reference
James Bentley
1 reference
Christian Jackisch
1 reference
Hans-Joachim Lück
1 reference
Justine Rochon
1 reference
Annamaria Hayden Zimmermann
1 reference
Elizabeth Eisenhauer
1 reference
AGO-OVAR
1 reference
NCIC CTG
1 reference
EORTC GCG
1 reference
11 September 2006
1 reference
24
1 reference
4699-4707
1 reference
29
1 reference
Identifiers
1 reference